R. Michael Carruthers, Chief Financial Officer at Edgewise Therapeutics, Inc. (EWTX), sold 90,000 shares at $15.78 ($1.4M) on 2024-01-23, disclosed to the SEC on 2024-01-25.
Scheduled sale ($1.4M) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| EWTX | SELL | 2024-09-24 | $5.7M | — | Filing → |
| EWTX | SELL | 2024-05-03 | $41K | — | Filing → |
| EWTX | SELL | 2023-05-03 | $12K | — | Filing → |